Neuromyelitis Optica Spectrum Disorder
Showing 1 - 25 of >10,000
Neuromyelitis Optica Spectrum Disorder Exposed to UPLIZNA®
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Pregnancy Related
- (no location specified)
Jun 9, 2023
NMO Spectrum Disorder, Azathioprine Adverse Reaction Trial in Nanning (Azathioprine)
Completed
- NMO Spectrum Disorder
- Azathioprine Adverse Reaction
-
Nanning, Guangxi, ChinaQingmeng Huang
Jun 8, 2023
Inebilizumab in Acute Neuromyelitis Optica Spectrum Disorders
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Inebilizumab
- oral immunosuppressant
- (no location specified)
Jun 5, 2023
Neuromyelitis Optica Spectrum Disorder Relapse Trial in Tianjin (Ruxolitinib)
Withdrawn
- Neuromyelitis Optica Spectrum Disorder Relapse
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Jun 10, 2023
Neuromyelitis Optica Spectrum Disorder Trial (Mitoxantrone Hydrochloride Liposome Injection)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- Mitoxantrone Hydrochloride Liposome Injection
- (no location specified)
Sep 20, 2022
NMO Spectrum Disorder Trial (Acceptance and Commitment Therapy)
Not yet recruiting
- NMO Spectrum Disorder
- Acceptance and Commitment Therapy
- (no location specified)
Apr 21, 2023
Restless Legs Syndrome in People With Neuromyelitis Optica
Recruiting
- Neuromyelitis Optica
- Restless Legs Syndrome
- assessments
-
İzmir, TurkeyDokuz Eylul University
Oct 6, 2022
Neuromyelitis Optica Spectrum Disorder, NMOSD, AQP4+ NMOSD Trial
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- +2 more
- (no location specified)
Jul 21, 2023
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (MIL62, Placebo)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
- MIL62
- Placebo
- (no location specified)
May 26, 2022
Neuromyelitis Optica Spectrum Disorder, NMOSD Trial in Le Kremlin-bicêtre, Gdansk (Satralizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
- NMOSD
-
Le Kremlin-bicêtre, France
- +1 more
Aug 17, 2022
Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorder, NMO Spectrum Disorder Trial in Tianjin (Daratumumab, Placebo)
Recruiting
- Neuromyelitis Optica
- +2 more
- Daratumumab
- Placebo
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Oct 19, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Barcelona (Ravulizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Barcelona, SpainClinical Trial Site
Jul 6, 2022
Neuromyelitis Optica Trial in Boston (NMOSDCopilot smartphone application)
Not yet recruiting
- Neuromyelitis Optica
- NMOSDCopilot smartphone application
-
Boston, MassachusettsMassachussets General Hospital
Dec 21, 2022
Egyptian Patients With Neuromyelitis Optica Spectrum Disorder
Not yet recruiting
- Assessment of Serum FAM19A5level in Egyptian Patients With NMOSD
- serum level of FAM19A5
- (no location specified)
Jul 4, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Beijing (Orelabrutinib)
Not yet recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Beijing, Beijing, ChinaPeking Union Medical College Hospital, Chinese Academy of Medica
Mar 16, 2022
Neuromyelitis Optica, NMO Spectrum Disorder Trial in Rochester
Recruiting
- Neuromyelitis Optica
- NMO Spectrum Disorder
-
Rochester, MinnesotaMayo Clinic
Mar 11, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Xi'an (Ofatumumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
Xi'an, Shaanxi, ChinaTangdu Hospital
Aug 16, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Worldwide (Inebilizumab)
Recruiting
- Neuromyelitis Optica Spectrum Disorder
-
La Jolla, California
- +14 more
Jan 25, 2023
Immune Cells and Meningeal Lymphatic Drainage in Demyelinating
Recruiting
- Multiple Sclerosis
- +2 more
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Oct 19, 2022
Rare Neuroimmunologic Disorders
Recruiting
- Neuromyelitis Optica
- +3 more
-
Dallas, TexasThe University of Texas Southwestern Medical Center
May 9, 2022
NMO Spectrum Disorder Trial in Tianjin (Baricitinib)
Not yet recruiting
- NMO Spectrum Disorder
-
Tianjin, Tianjin, ChinaTianjin Medical University General Hospital
Mar 18, 2023
NMO Spectrum Disorder, Spasticity, Muscle Trial in Boston (Nabiximols, Placebo)
Not yet recruiting
- NMO Spectrum Disorder
- Spasticity, Muscle
- Nabiximols
- Placebo
-
Boston, MassachusettsMassachusetts General Hospital
Aug 2, 2023
Maintenance Plasma Exchange for Neuromyelitis Optica
Completed
- Neuromyelitis Optica
- +2 more
- Plasma exchange (PLEX)
-
Scottsdale, Arizona
- +1 more
Dec 7, 2021
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Neuromyelitis Optica Spectrum Disorder Trial in Wuhan (CT103A
Recruiting
- Autoimmune Diseases
- +5 more
- CT103A cells
- Cyclophosphamide and fludarabine
-
Wuhan, Hubei, ChinaTongji Hospital affiliated to Tongji Medical College of Huazhong
Dec 10, 2022
Neuromyelitis Optica Spectrum Disorder Trial in Waltham
Enrolling by invitation
- Neuromyelitis Optica Spectrum Disorder
-
Waltham, MassachusettsCorrona, LLC
May 10, 2021